"We have already exceeded 2004 revenues and are aggressively pursuing new business opportunities, including projects related to clinical trials," Faye O'Brien, senior business director of Icoria, said in the statement. Paradigm is the gene expression-profiling service unit of Research Triangle Park, NC-based Icoria.
The two-year EPA contract involves a custom microarray for zebrafish designed by Icoria and produced by Agilent, Paradigm said. That contract is also related to the study of environmental toxicants, the company said.
Of its third contract with the unnamed biotech company, Paradigm said only that its work is "underway and is expected to be completed by the third quarter of 2006."